Literature DB >> 21213025

Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding.

Satish K Singh1, Parag Kolhe, Anjali P Mehta, Steven C Chico, Alanta L Lary, Min Huang.   

Abstract

PURPOSE: To investigate the cause of unexpected and erratic increase in aggregation during long-term storage of an IgG2 monoclonal antibody in a trehalose formulation at -20°C.
METHODS: Frozen matrix was sampled, stored frozen at various temperatures and analyzed by SEC over time.
RESULTS: Aggregation increased with time at -20°C but not at -40°C or -10°C. The cause of the instability was the crystallization of freeze-concentrated trehalose from the frozen solute when the storage temperature exceeds the glass transition temperature of the matrix (-29°C). Crystallization at -20°C deprives the protein of the cryoprotectant, leading to a slow increase in aggregation. Storage at -10°C also leads to crystallization of trehalose but no increase in aggregation. It is hypothesized that significantly higher mobility in the matrix at -10°C allows protein molecules that are unfolded at the ice interface on freezing to refold back before significant aggregation can occur. In contrast, lack of mobility at -40°C prevents crystallization, refolding, and aggregation.
CONCLUSIONS: Aggregation in the frozen state when stored above the glass transition temperature is a consequence of balance between rate of crystallization leading to loss of cryoprotectant, rate of aggregation of the unfolded protein molecules, and rate of refolding that prevents aggregation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213025     DOI: 10.1007/s11095-010-0343-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying.

Authors:  Xiaolin Charlie Tang; Michael J Pikal
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 2.  Protein stability during freezing: separation of stresses and mechanisms of protein stabilization.

Authors:  Bakul S Bhatnagar; Robin H Bogner; Michael J Pikal
Journal:  Pharm Dev Technol       Date:  2007       Impact factor: 3.133

3.  Proteins in frozen solutions: evidence of ice-induced partial unfolding.

Authors:  G B Strambini; E Gabellieri
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

4.  The mechanism of cryoprotection of proteins by solutes.

Authors:  J F Carpenter; J H Crowe
Journal:  Cryobiology       Date:  1988-06       Impact factor: 2.487

5.  Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose.

Authors:  Jai K Kaushik; Rajiv Bhat
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

6.  Glycation during storage and administration of monoclonal antibody formulations.

Authors:  Stefan Fischer; Joerg Hoernschemeyer; Hanns-Christian Mahler
Journal:  Eur J Pharm Biopharm       Date:  2008-04-30       Impact factor: 5.571

7.  Freezing-induced phase separation and spatial microheterogeneity in protein solutions.

Authors:  Jinping Dong; Allison Hubel; John C Bischof; Alptekin Aksan
Journal:  J Phys Chem B       Date:  2009-07-30       Impact factor: 2.991

8.  The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations.

Authors:  Himanshu S Gadgil; Pavel V Bondarenko; Gary Pipes; Doug Rehder; Arnold McAuley; Natalie Perico; Tom Dillon; Margaret Ricci; Michael Treuheit
Journal:  J Pharm Sci       Date:  2007-10       Impact factor: 3.534

9.  Sorbitol crystallization can lead to protein aggregation in frozen protein formulations.

Authors:  Deirdre Murphy Piedmonte; Christie Summers; Arnold McAuley; Lejla Karamujic; Gayathri Ratnaswamy
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

Review 10.  Extrinsic fluorescent dyes as tools for protein characterization.

Authors:  Andrea Hawe; Marc Sutter; Wim Jiskoot
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

View more
  14 in total

1.  Mutual Influence of Mannitol and Trehalose on Crystallization Behavior in Frozen Solutions.

Authors:  Sampreeti Jena; Raj Suryanarayanan; Alptekin Aksan
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

Review 2.  Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.

Authors:  Satish K Singh; Donna L Luisi; Roger H Pak
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

3.  Beyond glass transitions: studying the highly viscous and elastic behavior of frozen protein formulations using low temperature rheology and its potential implications on protein stability.

Authors:  Jian Hua Gu; Alice Beekman; Tian Wu; Deirdre Murphy Piedmonte; Priti Baker; Michael Eschenberg; Michael Hale; Merrill Goldenberg
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

4.  Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.

Authors:  Friederike Plath; Philippe Ringler; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Melissa A Graewert; Dmitri Svergun; Gerald Gellermann; Christof Finkler; Jan O Stracke; Atanas Koulov; Volker Schnaible
Journal:  MAbs       Date:  2016-03-31       Impact factor: 5.857

5.  Ultrasonication as a potential tool to predict solute crystallization in freeze-concentrates.

Authors:  Vishard Ragoonanan; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2014-01-08       Impact factor: 4.200

6.  Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics.

Authors:  Congzhou Wang; Gail Sudlow; Zheyu Wang; Sisi Cao; Qisheng Jiang; Alicia Neiner; Jeremiah J Morrissey; Evan D Kharasch; Samuel Achilefu; Srikanth Singamaneni
Journal:  Adv Healthc Mater       Date:  2018-10-19       Impact factor: 9.933

7.  Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays.

Authors:  Robert J Kubiak; Nancy Lee; Yuan Zhu; William R Franch; Sophia V Levitskaya; Surekha R Krishnan; Varghese Abraham; Peter F Akufongwe; Christopher J Larkin; Wendy I White
Journal:  J Immunol Res       Date:  2016-07-10       Impact factor: 4.818

8.  Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.

Authors:  Vishal M Toprani; Neha Sahni; John M Hickey; George A Robertson; C Russell Middaugh; Sangeeta B Joshi; David B Volkin
Journal:  Vaccine       Date:  2017-05-24       Impact factor: 3.641

9.  Distribution of Protein Content and Number of Aggregates in Monoclonal Antibody Formulation After Large-Scale Freezing.

Authors:  Astrid Hauptmann; Georg Hoelzl; Thomas Loerting
Journal:  AAPS PharmSciTech       Date:  2019-01-10       Impact factor: 3.246

10.  Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.

Authors:  Astrid Hauptmann; Katja Podgoršek; Drago Kuzman; Stanko Srčič; Georg Hoelzl; Thomas Loerting
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.